Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilisation of Benralizumab in the Clinical Practise in Severe Eosinophilic Asthma Patients in Switzerland

NCT03907137 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03907137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03907137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilisation of Benralizumab in the Clinical Practise in Severe Eosinophilic Asthma Patients in Switzerland
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 21, 2019
Completion date
January 4, 2023
Enrollment
79 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

severe eosinophilic asthma